Biotechnology Product Manufacturing Industry Engenders Medicines, Treatments, And Vaccines

Whether eastern-based medicine or western medicine, there is a multitude of so-called healing modalities. A plethora of industries is available to get their share of the huge financial pie. The pharmaceutical industry is one of the

This paper will be broken down into two main sections by the controversies and advancements in biotechnology. It will also end with a brief summary of my opinion on the use of biotechnology in modern day society and why I believe so. I will also add an additional works cited page that contains the URLs to all of the sources I received my information

Mackey, T. M. and Liang, B. A. (2012), Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property. Drug Discovery Today, 17(23-24): 1254 1257.

While there are a great amount of advantages to the developments of biological synthetic engineering, the disadvantages are a pressing matter as well. As biological engineering develops, the sequences with which the scientists work are becoming more complex(pbs.org). The sequences are still simple enough, however, to be followed by just about anyone who knows things about science. Therefore if they are given to people who are not meant to obtain them they can be used to create very dangerous objects. The federal government has spoken about the possibility of bioterrorist attacks and the spreading of diseases that have been contained but do not actively have cures, such as the bird flu and smallpox. Because of the many possible uses of the advancement of biological engineering, it continues to be approached with much caution, for the safety of the American people(pbs.org).

Located in South San Francisco, CA, Genentech was started in 1976 by a biochemist Dr. Herbert Boyer and Robert A. Swanson. From 1995-2009 Arthur Levinson had become the CEO of Genentech; presently it is Ian T. Clark. Genentech is a leading biotechnology company, using human genetic information to discover, develop, manufacture and commercialize medicines to treat people with serious or life-threatening medical conditions (2014). Biotechnology is the technology based on the science of cellular and biomolecular processes to develop technologies and products that help improve peoples’ lives and the health of our environment. How biotechnology uses cellular and biomolecular processes are by using molecular mechanisms by which genetic and

As part of an annual review of Pharmacorp PLC management practices, this report explores on all aspects of Pharmacorp’s managerial and business strategy by presenting an appraisal of the main risks and opportunities associated with pharmaceutical research. It will also look at the latest business models and managerial techniques to manage risks and opportunities upon the latest research and practices of change and innovation management. Other than that, this report will provide some steps and suggestions that will helpful Pharmacorp to maintain an innovative of its competitive business environment by defining the skills that Pharmacorp’s change agents or innovation managers should employ. Along with that, the use of Pharmacorp’s organisational

Actually the transition from laboratory accomplishment towards human clinical trials has develop into so complicated manners that former NIH Director Elias Zerhouni has designate it the "valley of death. University’s laboratories are examining cells and enzymes and investigate models of human diseases in animals. Usually, after these discoveries, the duty of testing the potential drug in humans is a part of industries. But from the last few years Pharmaceutical companies are focusing on the drug which already passed the regulatory hurdles due to increasing clinical trial cost, expiration of patent and regulatory stringency. New trend has come up that big pharmaceutical companies are willing buy small pharmaceutical company whose research is in final stage and promising the drug approval from the FDA. According to Center Watch, the clinical trial business association, the figure of clinical trials including the United States and worldwide studies, decrease in 2012 compared to previous four years. These developments disturb researchers who have newly identified compounds in the laboratory that they were thinking that it could be effective to treat dengue viruses, west Nile virus, and hepatitis C virus. These new innovative compounds can be drug by exploring a different route i.e. university, industry, and equipped capabilities, Drug improvement Ventures may be able to survive the economic environment by

Scientists, Physicians, and Researchers strive every day to understand how medicine can positively affect the lives of people within their community and around the world. They also work towards discovering new medicine that will be safe and effective for the public, which often leads to a new breakthrough for diseases and other controlled conditions. “ The progress made in reducing death rates from heart disease and stroke for example, is saving the lives of more than 1 million Americans each year” (Williams & Torrens, 2008). Pharmaceutical research plays a major role in giving medical staff options to adapt treatment plans to the patient’s needs. The use of pharmaceutical drugs can also reduce hospitalizations and prevent future complications or side effects from the patient’s illness. Funding a new drug can cost billions of dollars for research companies and has a major effect on the indirect and direct cost to treat diseases for consumers. “The drug makers have benefited from their ability to set and raise prices for patented products” (Hao & Nwaeze, 2015). Conclusively, in healthcare, pharmaceutical companies help improve the quality of life in society and are involved in setting the standard to live more productive lives.

Genentech was founded in 1976 by Robert Swanson and Herbert Boyer. The company was one of the first biotechnology companies. Its mission was to develop manufacture and commercialize biotherapeutics drugs. Genentech main focus was in areas of oncology, immunology and tissue growth and repair. After few years of company’s development, Genentech scientists successfully produced the first therapeutic proteins which involve human genes. Evaluating with the VRIO analysis, Genentech is valuable, rare, costly to imitate, and organized to capture value. The main advantage of the company is that best scientists in the world doing their own research, focusing in produce the best-in-class medicines with leading-edge scientific knowledge. Genentech has a rare resource, which provide opportunity for scientists to collaborate with one another. The working environment is also rare, which provide the scientists with a 275,000 square foot state of the art facility. Herbert Boyer owns the first major patent in the new biotechnology sector, which no other companies can duplicate or purchase those patent rights. This factor is costly to imitate because the company has the patent for a period of time, thus creating a competitive advantage. Genentech is organized to capture value and sophisticated selection criteria in order to move projects from discovery phase to commercialization. The projects are mainly based on scientific rationale, critical medical needs, significant market opportunities,

Biotechnology is technology based on living organisms. It harnesses cellular and biomolecular processes to develop technologies or products which are immensely useful to mankind. Biotechnology modifies living organisms according to our needs. Humans have employed this tool in the fields of agriculture, food industry and medicine for more than 6000 years. We see numerous biotechnological applications in our every-day life. Preparation of food products like bread, cheese and preservatives in dairy products are all outcomes of this great scientific tool (Biotechnology Industry Organization).

Although the biotechnology is a little more than a quarter century old, it has promoted significant advances in the food production process. First looking for resistances in plants for specifics herbicides, after mitigating the uses of insecticides in crops, maybe in future a tool to produce pharmaceuticals (Chassy, 2007). Researches show that some genetically modified organisms (GMOs) don't have impact on the human and animal health directly - toxicology, and allergies, and anti-nutrition assay -, as well as they show the GMOs haven't changed the bacteria gut in swine and chicken (Deng, Zhou, X.,, Zhou, P., Du, Hou, Yang, Y., Tan, ...,

The process of creating a new drug is essential in an ever-evolving society. Every person craves for new and innovative interventions to his or her ailments. As a result, the research community works daily to aid in this request. However, the process from bench to bedside is a long and complicated one. It can take from 10 and up to 15 years from beginning to end to develop just one drug (“From Lab,” 2014). By this time, there have been countless new discoveries regarding the disease it was targeted for. This can result in a compromised effectivity in the drug. On the other hand, the time must be dedicated to ensuring efficacy and safety. Different stages of studies throughout this time will also aid in ensuring that the drug will still be

The Biotechnology Innovation Organization defines the biotech industry as, “technology based on biology - biotechnology harnesses cellular and bio-molecular processes to develop technologies and products that help improve our lives and the health of our planet.” This Vital sector of the free market is comprised of many great companies. The five choices that I have selected are, in my opinion, the best choices to represent the biotechnology industry.

Technological: The pharmaceutical industry has seen many modern scientific advances, this meant that in order to remain a big player a company must be constantly adapting their products in order to keep up with their competition. In order to achieve this companies must increase their investment and spending on research and development in order to encourage innovation. (McGee et al, 2005)

The creation of a business segment focusing on innovation would attract top talents to create new patentable drugs.